Trial ID or NCT#
The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.
A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma
- - Diagnosis of choroidal melanoma
- - Have known contraindications or sensitivities to the study drug
Contact us to find out if this trial is right for you.
About this Clinical Trial
Your Message Will Go ToMariana Nunez
Go Back To The Trial